Forget charts and experts
Death cross, golden cross, double cross, out the window on this one.
Stock is rising on speculation that the soon to be released phase 3 result for acne drug BPX-01 will be great...we will see.
Compare to ....
Proactiv has been a spectacular success for its makers, two dermatologists in the San Francisco Area, and the company that markets it, Guthy-Renker. Its annual sales, $1.5 billion, tower over the rest of the acne treatment industry.
So what’s in this blockbuster drug? After all, the basic “Proactiv System” will cost you $19.95 (though it’s “a $72 value”). The short answer is not much. Make a few clicks around Proactiv’s website and you’ll find out the active compound is benzoyl peroxide. That’s the same stuff in Stridex, Clearasil and just about every nonprescription acne medication available in drugstore aisles across America. A tube of the same compound costs $5.25 at my local pharmacy.
They made 1.5 billion with benzoyl peroxide..that already existed in over the counter products, they just used justin beiber to market it. genius.
BPMX has BPX-01 coming out of phase 3. It is a TOPICAL antibio that BYPASSES ingestion.
If it worked,,, and goes on to pass later trials and get approved, the market will be well over proactives 1.5 billion.
That's why charts dont matter on this one,,,the phase 3 results DO.
And that's why its up 14% just today :)
We expect phase 3 data any day now
